UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

JUN is a key transcriptional regulator of the unfolded protein response in acute myeloid leukemia

Leukemia, 2017-05, Vol.31 (5), p.1196-1205

2017

Volltextzugriff (PDF)

Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia

Leukemia, 2015-04, Vol.29 (4), p.828-838

2015

Volltextzugriff (PDF)

Dissection of CD20 regulation in lymphoma using RNAi

Leukemia, 2016-12, Vol.30 (12), p.2409-2412

2016

Volltextzugriff (PDF)

Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia

Leukemia, 2015-06, Vol.29 (6), p.1243-1252

2015

Volltextzugriff (PDF)

Intensive consolidation versus oral maintenance therapy in patients 61 years or older with acute myeloid leukemia in first remission: results of second randomization of the AML HD98-B treatment Trial

Leukemia, 2006-04, Vol.20 (4), p.748-750

2006

Volltextzugriff (PDF)

RET-mediated autophagy suppression as targetable co-dependence in acute myeloid leukemia

Leukemia, 2018-10, Vol.32 (10), p.2189-2202

2018

Volltextzugriff (PDF)

Application of precision medicine in clinical routine in haematology—Challenges and opportunities

Journal of internal medicine, 2022-08, Vol.292 (2), p.243-261

2022

Volltextzugriff (PDF)

Phase iii study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

Leukemia, 2004-11, Vol.18 (11), p.1798-1803

2004

Volltextzugriff (PDF)

Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B

Haematologica (Roma), 2009-01, Vol.94 (1), p.54-60

2009

Volltextzugriff (PDF)

Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm

Blood, 2002-12, Vol.100 (13), p.4372-4380

2002

Volltextzugriff (PDF)

Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance

Leukemia, 2013-02, Vol.27 (2), p.353-361

2013

Volltextzugriff (PDF)

Risk-adapted postremission therapy in acute myeloid leukemia: results of the german multicenter AML HD93 treatment trial

Leukemia, 2003-08, Vol.17 (8), p.1521-1528

2003

Volltextzugriff (PDF)

Widespread over-expression of the non-clustered homeobox gene HLX in acute myeloid leukemia

Haematologica (Roma), 2012-10, Vol.97 (10), p.1453-1453

Frohling, S.

2012

Volltextzugriff (PDF)

Ligand-induced MET signaling as targetable codependence in acute myeloid leukemia

Haematologica (Roma), 2012-08, Vol.97 (8), p.1118-1118

Frohling, S.

2012

Volltextzugriff (PDF)

JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model

Blood, 2006-10, Vol.108 (8), p.2770-2779

2006

Volltextzugriff (PDF)

Design and Validation of DNA Probe Sets for a Comprehensive Interphase Cytogenetic Analysis of Acute Myeloid Leukemia

Blood, 1996-11, Vol.88 (10), p.3962-3971

1996

Volltextzugriff (PDF)

High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia

Leukemia, 2005-06, Vol.19 (6), p.978-983

2005

Volltextzugriff (PDF)

The prognostic value of MLL-AF9 detection in patients with t(9;11)(p22;q23)-positive acute myeloid leukemia

Haematologica (Roma), 2005-12, Vol.90 (12), p.1626-1634

2005

Volltextzugriff (PDF)

Rare occurrence of the JAK2 V617F mutation in AML subtypes M5, M6, and M7

Blood, 2006-02, Vol.107 (3), p.1242-1243

2006

Volltextzugriff (PDF)

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations

Blood, 2005-12, Vol.106 (12), p.3740-3746

2005

Volltextzugriff (PDF)

Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias

Blood, 1997-03, Vol.89 (6), p.2036-2041

1997

Volltextzugriff (PDF)

Comparison of Cytogenetic and Molecular Cytogenetic Detection of Chromosome Abnormalities in 240 Consecutive Adult Patients With Acute Myeloid Leukemia

Journal of clinical oncology, 2002-05, Vol.20 (10), p.2480-2485

2002

Volltextzugriff (PDF)

Cdx4 is dispensable for murine adult hematopoietic stem cells but promotes MLL-AF9-mediated leukemogenesis

Haematologica (Roma), 2010-10, Vol.95 (10), p.1642-1650

2010

Volltextzugriff (PDF)

Mutation analysis of the transcription factor PU.1 in younger adults (16 to 60 years) with acute myeloid leukemia: a study of the AML Study Group Ulm (AMLSG ULM)

Blood, 2003-11, Vol.102 (10), p.3850-3851

2003

Volltextzugriff (PDF)

Cooperation of BRAF(F595L) and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling

Leukemia, 2016-04, Vol.30 (4), p.937-946

2016

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Aktive Filter

ThemaHematology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(52)

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(50)
Science & Technology
(50)
Humans
(41)
Mutation
(18)
Middle Aged
(17)
Oncology
(17)
Leukemia, Myeloid, Acute - Genetics
(16)
Male
(16)
Adult
(15)
Biological And Medical Sciences
(15)
Female
(15)
Leukemia
(15)
Medical Sciences
(15)
Prognosis
(14)
Hematologic And Hematopoietic Diseases
(13)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(13)
Animals
(12)
Medicine
(12)
Acute Myeloid Leukemia
(11)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(18)
Leukemia
(15)
Haematologica
(7)
Blood Advances
(2)
European Journal Of Haematology
(2)
Best Practice & Research. Clinical Haematology
(1)
Blood Purification
(1)
Ejhaem
(1)
Experimental Hematology
(1)
Hemasphere
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

JUN is a key transcriptional regulator of the unfolded protein response in acute myeloid leukemia

Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia

Dissection of CD20 regulation in lymphoma using RNAi

Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia

Intensive consolidation versus oral maintenance therapy in patients 61 years or older with acute myeloid leukemia in first remission: results of second randomization of the AML HD98-B treatment Trial

RET-mediated autophagy suppression as targetable co-dependence in acute myeloid leukemia

Application of precision medicine in clinical routine in haematology—Challenges and opportunities

Phase iii study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B

Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm

Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance

Risk-adapted postremission therapy in acute myeloid leukemia: results of the german multicenter AML HD93 treatment trial

Widespread over-expression of the non-clustered homeobox gene HLX in acute myeloid leukemia

Ligand-induced MET signaling as targetable codependence in acute myeloid leukemia

JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model

Design and Validation of DNA Probe Sets for a Comprehensive Interphase Cytogenetic Analysis of Acute Myeloid Leukemia

High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia

The prognostic value of MLL-AF9 detection in patients with t(9;11)(p22;q23)-positive acute myeloid leukemia

Rare occurrence of the JAK2 V617F mutation in AML subtypes M5, M6, and M7

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations

Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias

Comparison of Cytogenetic and Molecular Cytogenetic Detection of Chromosome Abnormalities in 240 Consecutive Adult Patients With Acute Myeloid Leukemia

Cdx4 is dispensable for murine adult hematopoietic stem cells but promotes MLL-AF9-mediated leukemogenesis

Mutation analysis of the transcription factor PU.1 in younger adults (16 to 60 years) with acute myeloid leukemia: a study of the AML Study Group Ulm (AMLSG ULM)

Cooperation of BRAF(F595L) and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling

Aktive Filter

Suchergebnisse filtern